These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 17068132)

  • 1. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.
    Kharitonenkov A; Wroblewski VJ; Koester A; Chen YF; Clutinger CK; Tigno XT; Hansen BC; Shanafelt AB; Etgen GJ
    Endocrinology; 2007 Feb; 148(2):774-81. PubMed ID: 17068132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice.
    Patel V; Joharapurkar A; Dhanesha N; Kshirsagar S; Patel K; Bahekar R; Shah G; Jain M
    Can J Physiol Pharmacol; 2013 Dec; 91(12):1009-15. PubMed ID: 24289070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF-21 as a novel metabolic regulator.
    Kharitonenkov A; Shiyanova TL; Koester A; Ford AM; Micanovic R; Galbreath EJ; Sandusky GE; Hammond LJ; Moyers JS; Owens RA; Gromada J; Brozinick JT; Hawkins ED; Wroblewski VJ; Li DS; Mehrbod F; Jaskunas SR; Shanafelt AB
    J Clin Invest; 2005 Jun; 115(6):1627-35. PubMed ID: 15902306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction.
    Mai K; Schwarz F; Bobbert T; Andres J; Assmann A; Pfeiffer AF; Spranger J
    Metabolism; 2011 Feb; 60(2):306-11. PubMed ID: 20362303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
    Kalaiarasi P; Kaviarasan K; Pugalendi KV
    Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in lipoprotein concentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca mulatta).
    Hannah JS; Verdery RB; Bodkin NL; Hansen BC; Le NA; Howard BV
    J Clin Endocrinol Metab; 1991 May; 72(5):1067-72. PubMed ID: 2022707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats.
    Lai MH; Chen YY; Cheng HH
    Int J Vitam Nutr Res; 2006 Nov; 76(6):391-7. PubMed ID: 17607959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys.
    Andersen B; Straarup EM; Heppner KM; Takahashi DL; Raffaele V; Dissen GA; Lewandowski K; Bödvarsdottir TB; Raun K; Grove KL; Kievit P
    Int J Obes (Lond); 2018 Jun; 42(6):1151-1160. PubMed ID: 29892039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats.
    Anandh Babu PV; Sabitha KE; Shyamaladevi CS
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1184-9. PubMed ID: 17184499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.
    Gaich G; Chien JY; Fu H; Glass LC; Deeg MA; Holland WL; Kharitonenkov A; Bumol T; Schilske HK; Moller DE
    Cell Metab; 2013 Sep; 18(3):333-40. PubMed ID: 24011069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function.
    Wu K; Liang T; Duan X; Xu L; Zhang K; Li R
    Food Chem Toxicol; 2013 Oct; 60():341-7. PubMed ID: 23927877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible antidiabetic and antihyperlipidaemic effect of fermented Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats.
    Odetola AA; Akinloye O; Egunjobi C; Adekunle WA; Ayoola AO
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):808-12. PubMed ID: 16922811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal caffeine ingestion induces transgenerational neuroendocrine metabolic programming alteration in second generation rats.
    Luo H; Deng Z; Liu L; Shen L; Kou H; He Z; Ping J; Xu D; Ma L; Chen L; Wang H
    Toxicol Appl Pharmacol; 2014 Feb; 274(3):383-92. PubMed ID: 24321341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel peroxisome proliferator--activated receptor alpha/gamma dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys.
    Ding SY; Tigno XT; Braileanu GT; Ito K; Hansen BC
    Metabolism; 2007 Oct; 56(10):1334-9. PubMed ID: 17884441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys.
    Véniant MM; Komorowski R; Chen P; Stanislaus S; Winters K; Hager T; Zhou L; Wada R; Hecht R; Xu J
    Endocrinology; 2012 Sep; 153(9):4192-203. PubMed ID: 22798348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.